Goldman Sachs’s Amedisys AMED Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $23.9M | Buy |
|
|||||
2025
Q1 | $9.53M | Sell |
|
|||||
2024
Q4 | $14.3M | Buy |
|
|||||
2024
Q3 | $9.49M | Sell |
|
|||||
2024
Q2 | $102M | Buy |
|
|||||
2024
Q1 | $5.89M | Sell |
|
|||||
2023
Q4 | $12.8M | Buy |
|
|||||
2023
Q3 | $9.59M | Buy |
|
|||||
2023
Q2 | $8.62M | Buy |
|
|||||
2023
Q1 | $3.81M | Sell |
|
|||||
2022
Q4 | $9.01M | Buy |
|
|||||
2022
Q3 | $8.78M | Buy |
|
|||||
2022
Q2 | $7.75M | Buy |
|
|||||
2022
Q1 | $10.6M | Sell |
|
|||||
2021
Q4 | $10.6M | Sell |
|
|||||
2021
Q3 | $10.9M | Buy |
|
|||||
2021
Q2 | $16.7M | Sell |
|
|||||
2021
Q1 | $19.3M | Sell |
|
|||||
2020
Q4 | $26M | Buy |
|
|||||
2020
Q3 | $14.7M | Sell |
|
|||||
2020
Q2 | $29.2M | Buy |
|
|||||
2020
Q1 | $16.2M | Sell |
|
|||||
2019
Q4 | $21.4M | Buy |
|
|||||
2019
Q3 | $13.3M | Buy |
|
|||||
2019
Q2 | $10.5M | Sell |
|
|||||
2019
Q1 | $22.9M | Sell |
|
|||||
2018
Q4 | $35M | Sell |
|
|||||
2018
Q3 | $41.8M | Buy |
|
|||||
2018
Q2 | $23.9M | Sell |
|
|||||
2018
Q1 | $21.5M | Buy |
|
|||||
2017
Q4 | $7.89M | Buy |
|
|||||
2017
Q3 | $5.04M | Buy |
|
|||||
2017
Q2 | $3.34M | Sell |
|
|||||
2017
Q1 | $8.64M | Buy |
|
|||||
2016
Q4 | $6.23M | Buy |
|
|||||
2016
Q3 | $5.76M | Buy |
|
|||||
2016
Q2 | $5.54M | Buy |
|
|||||
2016
Q1 | $2.98M | Buy |
|
|||||
2015
Q4 | $1.57M | Sell |
|
|||||
2015
Q3 | $2.62M | Buy |
|
|||||
2015
Q2 | $1.26M | Buy |
|
|||||
2014
Q4 | – | Sell |
|
|||||
2014
Q3 | $273K | Sell |
|
|||||
2014
Q2 | $772K | Buy |
|
|||||
2014
Q1 | $541K | Sell |
|
|||||
2013
Q4 | $1.42M | Buy |
|
|||||
2013
Q3 | $867K | Sell |
|
|||||
2013
Q2 | $927K | Buy |
|